𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized, Double-Blind, Placebo-Controlled Crossover Study in Men with Prostate Cancer and Rising PSA: Effectiveness of a Dietary Supplement

✍ Scribed by Fritz H. Schröder; Monique J. Roobol; Egbert R. Boevé; Reneé de Mutsert; Sonja D. Zuijdgeest-van Leeuwen; I. Kersten; Mark F. Wildhagen; Ardy van Helvoort

Book ID
113609035
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
326 KB
Volume
48
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dietary intervention in prostate cancer
Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study
✍ Ries Kranse; Pieter C. Dagnelie; Monique C. van Kemenade; Frank H. de Jong; Jan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The objective of this study was to show or to exclude an effect of dietary supplement on rising prostate‐specific antigen (PSA) levels. We have studied the effect of a dietary supplement (verum, administered for 6 weeks) containing plant estrogens, antioxidants, including carotenoids, s

The antiosteoporotic efficacy of intrave
The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade : A double blind, randomized, placebo-controlled crossover study
✍ Terrence H. Diamond; Julie Winters; Angie Smith; Paul De Souza; John H. Kersley; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. Prostate carcinoma therapy with combined androgen blockade may result in high bone-turnover with significant bone loss. This study was undertaken to evaluate the antiosteoporotic efficacy of intravenous pamidronate in a double blind, randomized, placebo-controlled, crossover study.